🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 007002108 (prev. 76133L103 )
- Market Cap
- Small Cap
- IPO
- 1/26/2018 · $15.00/share
- Previous Symbol
- TORC (changed 9/18/2020)
- Previous Name
- resTORbio, Inc.
Business: resTORbio, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.
Notes: Sept. 15, 2020 -- Adicet Bio, Inc., a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases, today announced the completion of its previously announced merger with resTORbio, Inc. (previously trading on Nasdaq under the symbol “TORC”). The new combined company will operate under the name Adicet Bio, Inc. and will commence trading on the Nasdaq Global Market under the ticker symbol “ACET” on September 16, 2020. In connection with the closing of the merger, resTORbio effected a 7:1 reverse split of its common stock.
Company Contact
- CEO
- Chen Schor
- CFO
- Nick Harvey
- Headquarters
- 131 Dartmouth Street, 3rd Floor, Boston, MA 02116
- Phone
- 650-503-9095
- Investor Relations
- Anne Bowdidge · 857-315-5528 · abowdidge@adicetbio.com